ArticleNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2025
Efficacy of minimally invasive hematoma evacuation in treating traumatic intracranial hematoma: a retrospective cohort study.
Article in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Advances in Stereotactic Hematoma Evacuation for Hypertensive Intracerebral Hemorrhage and the Value of Multimodal Monitoring.Cerebrovascular diseases (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study aimed to evaluate the clinical efficacy and safety of minimally invasive hematoma evacuation for the treatment of traumatic intracranial hematoma (TIH).
methodsNinety patients diagnosed with traumatic intracerebral hematoma at Shengli Oilfield Central Hospital from August 2019 to September 2023 were selected as the study subjects. The patients were divided into the craniotomy group (C group, n = 45) and the minimally invasive hematoma evacuation group (MIHE group, n = 45). Patients in group MIHE were treated with minimally invasive hematoma evacuation according to the amount and location of the TIH. The patients' baseline characteristics, the good prognosis rate, the neurological function index, the hospitalization cost and the incidence rate of complications were compared between the two groups. The status of the patients after surgical treatment was determined according to the Glasgow Outcome Scale.
resultsThe good prognosis rate in the MIHE group (39, 86.67%) was significantly higher than that in the C group (31, 68.89%) (p < 0.05). National Institute of Health stroke scale (NIHSS) scores were significantly lower in the MIHE group than in the C group (p < 0.05). The hospitalization cost and hospitalization time in the MIHE group were significantly lower than those in the C group (p < 0.05). The total incidence rate of complications in the MIHE group (20, 44.44%) was significantly lower than that in the C group (11, 24.44%) (p < 0.05).
conclusionFor some patients, minimally invasive hematoma evacuation is a more effective treatment strategy than craniotomy for patients with TIH. It has the advantages of less surgical trauma, complete clearance of hematoma and fewer postoperative complications, which is conducive to the recovery of neurological function and postoperative rehabilitation.
Indexed as
Identifiers
39760820What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.